article thumbnail

A Health Consumer Bill of Rights: Assuring Affordability, Access, Autonomy, and Equity

Jane Sarashon

In addition to highlighting the Patient’s Bill of Rights, NABIP’s keynotes and general sessions will speak to similar topics being brainstormed at VIVE this week — including mental health, maternal health, pharmacy and prescription drugs (pricing, PBMs), population health, and Medicare and Medicaid innovations.

ACA 118
article thumbnail

Will Consumers Cross the Cost-and-Trust Chasm Between Prescription Drugs and Hospitals?

Health Populi

When asked what factors contribute to rising health care costs in America, most consumers cite the cost of prescription drugs. Taken together, these two data points demonstrate the potent political import of prescription drug prices as the U.S. approaches the 2020 Presidential election.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

In U.S. Health Care, It’s Still the Prices, Stupid – But Transparency and Consumer Behavior Aren’t Working As Planned

Health Populi

It’s mainstream patient experience these days for people to experience a surprise medical bill or be challenged on a new prescription that a payor denies as a first-step therapy. That workers highly value their health benefits is no surprise.

article thumbnail

Hall Render’s Health Provider News – February 25, 2022

Hall Render

Florida bill extending COVID-19 liability protections for health workers on its way to Gov. New report shows Tampa Bay hospitals not following medical bill transparency law. Whitmer signs bills designed to lower prescription drug prices in Michigan. Citrus Memorial Hospital to change name in March.

article thumbnail

Health Provider News – February 18, 2022

Hall Render

Lawmaker: Revisions coming to Georgia mental health bill. Local hospitals begin enforcing medical worker vaccine mandates. Family shocked after receiving medical bill that cost more than double what they expected. top medical official doesn’t expect a COVID surge after Mardi Gras.

article thumbnail

Health Provider News

Hall Render

Health Policy Commission still missing key document in Steward sale to Optum Local obesity drug developer lands deal worth up to $600M with Novo Nordisk Mass.

article thumbnail

Gallup Reveals Americans’ Views on Industry Are the Lowest Since 2008 – Implications for Healthcare and Pharma

Jane Sarashon

The decline of the pharma industry reputation is an important reality-check here given that even Republican voters have been keen to see greater regulation of prescription drug pricing in recent health tracking polls.